Fibromuscular dysplasia natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Mohsen Basiri (talk | contribs)
nocaptcha
1,390 edits
Mohsen Basiri (talk | contribs)
nocaptcha
1,390 edits
Line 17: Line 17:


===Natural History===
===Natural History===
Since,Fibromuscular dysplasia can involve virtually every artery of the body, thus the clinical presentations of FMD vary widely and are determined by the vessels territories that are involved. in the FMD  Multivessel involvement is common,too
The clinical presentations may result from the stenosis, ischemia, dissection and occlusion,rupture of aneurysms and embolization of intravascular thrombi from dissection or aneurysms.<ref>{{Cite journal
| author = [[Jeffrey W. Olin]] & [[Brett A. Sealove]]
| title = Diagnosis, management, and future developments of fibromuscular dysplasia
| journal = [[Journal of vascular surgery]]
| volume = 53
| issue = 3
| pages = 826–836
| year = 2011
| month = March
| doi = 10.1016/j.jvs.2010.10.066
| pmid = 021236620
}}</ref><ref>{{Cite journal
| author = [[Jeffrey W. Olin]], [[Heather L. Gornik]], [[J. Michael Bacharach]], [[Jose Biller]], [[Lawrence J. Fine]], [[Bruce H. Gray]], [[William A. Gray]], [[Rishi Gupta]], [[Naomi M. Hamburg]], [[Barry T. Katzen]], [[Robert A. Lookstein]], [[Alan B. Lumsden]], [[Jane W. Newburger]], [[Tatjana Rundek]], [[C. John Sperati]] & [[James C. Stanley]]
| title = Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association
| journal = [[Circulation]]
| volume = 129
| issue = 9
| pages = 1048–1078
| year = 2014
| month = March
| doi = 10.1161/01.cir.0000442577.96802.8c
| pmid = 24548843
}}</ref>


===Complications===
===Complications===

Revision as of 01:35, 13 June 2018

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia natural history, complications and prognosis

CDC on Fibromuscular dysplasia natural history, complications and prognosis

Fibromuscular dysplasia natural history, complications and prognosis in the news

Blogs on Fibromuscular dysplasia natural history, complications and prognosis

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Natural History, Complications, and Prognosis

Natural History

Complications

  • Common complications of [disease name] include:
    • [Complication 1]
    • [Complication 2]
    • [Complication 3]

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
  • Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Fibromuscular_dysplasia_natural_history,_complications_and_prognosis&oldid=1476451"